L3VLUP
ProSign in

MRNA in the 13F filings

Moderna Inc · CUSIP 60770K107

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 23 Jan 2026
Managers listing it
36
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 8 listed it in both
Shares listed
97,945,885
combined, among listed positions
Reported value
$2.9bn
combined, at the quarter end

Among the 92 comparable managers: 16 buyers (opened or added shares) and 20 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +21,478,320.

Managers listing MRNA in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

36 of 36 holders

ActionFiling
Fidelity (FMR LLC)28,045,311$827munder 0.1%Added+15,741,01417 Feb 2026 (the filing on sec.gov)
Baillie Gifford & Co20,580,514$607m0.50%Trimmed-1,266,15223 Jan 2026 (the filing on sec.gov)
Capital World Investors12,828,040$378m0.05%Newnew11 Feb 2026 (the filing on sec.gov)
Two Sigma Advisers LP7,729,700$228m0.44%Added+956,80017 Feb 2026 (the filing on sec.gov)
Two Sigma Investments LP7,342,096$217m0.31%Trimmed-187,88517 Feb 2026 (the filing on sec.gov)
Invesco Ltd7,029,694$207munder 0.1%Trimmed-1,186,46919 Feb 2026 (the filing on sec.gov)
D. E. Shaw & Co.5,182,759$153m0.08%Trimmed-963,61517 Feb 2026 (the filing on sec.gov)
Susquehanna International Group LLP1,615,399$48munder 0.1%Trimmed-343,29517 Feb 2026 (the filing on sec.gov)
Voloridge Investment Management LLC1,553,731$46m0.16%Added+584,32917 Feb 2026 (the filing on sec.gov)
Squarepoint Ops LLC975,195$29munder 0.1%Trimmed-187,07313 Feb 2026 (the filing on sec.gov)
Citadel Advisors LLC579,130$17munder 0.1%Trimmed-1,408,60117 Feb 2026 (the filing on sec.gov)
Renaissance Technologies LLC568,400$17munder 0.1%Newnew12 Feb 2026 (the filing on sec.gov)
Man Group PLC518,299$15munder 0.1%Trimmed-673,54417 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc494,013$15munder 0.1%Added+11,14817 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC452,529$13m0.05%Added+230,19213 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP405,206$12munder 0.1%Trimmed-9,45217 Feb 2026 (the filing on sec.gov)
Millennium Management LLC403,635$12munder 0.1%Trimmed-763,82517 Feb 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP244,594$7.2munder 0.1%Added+189,59413 Feb 2026 (the filing on sec.gov)
Woodline Partners LP204,709$6.0munder 0.1%Trimmed-43,06417 Feb 2026 (the filing on sec.gov)
Coatue Management LLC200,000$5.9munder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Walleye Capital LLC172,159$5.1munder 0.1%Added+22,64813 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd153,035$4.5munder 0.1%Trimmed-14,07617 Feb 2026 (the filing on sec.gov)
Marshall Wace LLP119,441$3.5munder 0.1%Trimmed-145,93213 Feb 2026 (the filing on sec.gov)
Tudor Investment Corp96,206$2.8munder 0.1%Trimmed-248,34517 Feb 2026 (the filing on sec.gov)
Neuberger Berman Group LLC93,920$2.8munder 0.1%Added+14,44027 Oct 2026 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (7)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
12 in Q3 2024 to 9 in Q2 2026

Tracked managers listing it, at least.

010203020192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
MRNA by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20182$287mn.a.n.a.
Q1 20193$688mn.a.n.a.
Q2 20192$167mn.a.n.a.
Q3 20192$126mn.a.n.a.
Q4 20195$449mn.a.n.a.
Q1 20208$1.0bnn.a.n.a.
Q2 20209$3.1bnn.a.n.a.
Q3 20206$3.1bnn.a.n.a.
Q4 202016$4.4bnn.a.n.a.
Q1 202118$8.0bnn.a.n.a.
Q2 202122$18.4bnn.a.n.a.
Q3 202127$27.6bnn.a.n.a.
Q4 202120$17.2bnn.a.n.a.
Q1 202216$11.8bnn.a.n.a.
Q2 202219$10.2bnn.a.n.a.
Q3 202222$8.4bnn.a.n.a.
Q4 202220$13.0bnn.a.n.a.
Q1 202317$11.2bnn.a.n.a.
Q2 202315$8.9bnn.a.n.a.
Q3 202312$7.2bnn.a.n.a.
Q4 20238$6.9bn55
Q1 20247$7.6bn35
Q2 202413$9.5bn94
Q3 202412$4.8bn94
Q4 202415$3.1bn133
Q1 202511$2.0bn94
Q2 202510$2.0bn73
Q3 20259$1.2bn54
Q4 202510$2.5bn1620
Q1 20269$4.8bn1719
Q2 20269$8.0bn1717

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

MRNA and GILD →MRNA and AMGN →MRNA and ARGX →Choose a stock to compare with MRNA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own MRNA, latest filings →Back to the 13F Explorer →